Birchview Capital, LP Neuro Pace Inc Transaction History
Birchview Capital, LP
- $117 Million
- Q4 2024
A detailed history of Birchview Capital, LP transactions in Neuro Pace Inc stock. As of the latest transaction made, Birchview Capital, LP holds 10,000 shares of NPCE stock, worth $137,700. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$137,700% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
65Shares Held
21.7MCall Options Held
23.2KPut Options Held
800-
Kck Ltd. Tortola, D85.27MShares$72.6 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$46.9 Million1.03% of portfolio
-
Morgan Stanley New York, NY2.49MShares$34.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$33.5 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$20.4 Million7.02% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $342M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...